Infliximab News and Research

RSS
Infliximab is a monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of drugs called monoclonal antibodies.
Using in vivo self-assembled siRNA as part of combination therapy for ulcerative colitis

Using in vivo self-assembled siRNA as part of combination therapy for ulcerative colitis

Study shows how innate lymphoid cells may help to treat inflammatory bowel disease

Study shows how innate lymphoid cells may help to treat inflammatory bowel disease